Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study

Jasielec, J; Zonder, J; Derman, BA; Reece, DE; Cole, CE; Berdeja, JG; Wolfe, B; Major, S; Tinari, KM; Stefka, A; Fazzi, F; Whelan, M; Gleason, C; McIver, A; Andreatos, E; Libao, BM; Juergens, D; Griffith, K; Jakubowiak, A

BLOOD, 2020; 136 ():